ReviewInsects2026
Evaluating Sequence Foundation Models for Insect Olfactory Gene Discovery: Failure Modes, Evidence Standards, and a Benchmark Agenda.
Review in Insects, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Genome-scale searches for insect olfactory genes are vulnerable to rapid receptor divergence, tandem duplication, fragmented gene models, circular labels, and evolutionary leakage between training and test data. Sequence foundation models trained on DNA or proteins may extend homology-based annotation, but available evidence does not support their use as autonomous annotators or direct predictors of sensory function. This critical review organizes the problem around annotation failures rather than model catalogues. We distinguish six inference levels, from candidate locus detection to organism-level function, and define task-specific high-confidence reference criteria. We also propose a benchmark using biological hard negatives, sequence-cluster and taxonomic holdouts, conventional baselines, calibration, abstention, and workload-aware retrieval metrics. Evidence integration is defined operationally as a pipeline that retains model scores alongside similarity, domains, topology, phylogeny, expression, and assay evidence, without promoting a weak signal to a stronger biological claim. A published ESM-2-supported analysis of remote insect chemoreceptor homology illustrates both the potential and the current evidence boundary. A convincing benefit will require an incremental gain over transparent baselines under frozen biologically realistic splits, with reliable uncertainty and a clear route from ambiguous predictions to review or experiment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.